Subscribe To
Is a surprise coming for church & dwight (chd) this earnings season?
Church & Dwight (CHD) is seeing favorable earnings estimate revision activity and has a positive Zacks ...
November 2, 2023, 12:02 pm
Ncv: troubled history but novel concept
Virtus Convertible & Income Fund offers a high level of current income with a yield of 13.97%. The NCV closed-end fund heavily invests in convertible ...
November 2, 2023, 11:53 am
Enerpac tool group to present at the baird global industrial conference
MILWAUKEE--(BUSINESS WIRE)--Enerpac Tool Group Corp. (NYSE: EPAC) will present at the Baird Global Industrial Conference on Wednesday, November 8, 202...
November 2, 2023, 11:49 am
Safemoon and litecoin: safemoon loses over 65% of its value
SafeMoon and Litecoin: SafeMoon loses over 65% of its value The price of SafeMoon took a huge plunge ye...
November 2, 2023, 11:48 am
Crocs shares dive as hey dude struggles continue
Shares in Crocs dived as the footwear giant warned a sluggish fourth quarter would hit numbers for the full year. Revenues are forecast to be 1-4% do...
November 2, 2023, 11:46 am
Optimi health announces third and final tranche of cad $1,000,000 secured for debt financing
is pleased to announce it has entered into a non-dilutive Debt Financing Agreement (“DFA”) and Gene...
November 2, 2023, 11:44 am
Equities gain as fed signals potential end to rate hiking
Stocks rallied as investors reacted to the possible peak of the Federal Reserve’s historic tightening campaign ...
November 2, 2023, 11:44 am
Mondelēz sees online grocery growth provide competitive edge
Mondelēz International is seeing its growing eCommerce business lead to share gains against competitors. The confectionary, snack ...
November 2, 2023, 11:41 am
Starbucks stock shoots higher on 4q revenue and earnings beat
Starbucks Corp (NASDAQ:SBUX) has reported fourth-quarter revenue and earnings that came in well ahead ...
November 2, 2023, 11:37 am
Early warning news release holding of secure energy services inc. common shares by angelo, gordon & co., l.p.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) — This news releas...
November 2, 2023, 11:36 am
Tyler technologies' stock on track for largest gain since march 2020
Tyler Technologies Inc.'s stock TYL, +9.73% was up 10.2% on Thursday as one of the top-performing components of the S&P 500 SPX, +1.53%, after its thi...
November 2, 2023, 11:35 am
We are big bitcoin bulls, says microstrategy's michael saylor
Michael Saylor, MicroStrategy founder and executive chairman, joins 'Squawk on the Street' to discuss t...
November 2, 2023, 11:34 am
Linkedin just launched a new ai job coach for premium members
LinkedIn is adding an AI career coach to help Premium users with job-hunting. The company says the tool can help users see if a job is a good fit
November 2, 2023, 11:33 am
7 penny stocks to buy now according to analysts, targets up to 751%
The penny stock market is an enticing yet volatile landscape for investors seeking big rewards. While the chance to uncover the next hidden gem before...
November 2, 2023, 11:32 am
Us october challenger layoffs 36.84k vs 47.46k prior
Prior 47.46kUS-based employers announced 36,836 job cuts last month, a roughly 9% increase compared to the same period last year. That continues the t...
November 2, 2023, 11:30 am
Parker reports fiscal 2024 first quarter results
Sales increased 15% to $4.8 billion; organic sales increased 2% Segment operating margin was 21.3%, or a record 24.9% adjusted, an increase of 220 bas...
November 2, 2023, 11:30 am
Review control reputation management introduces new product to help gain additional share of the multi-billion dollar review and reputation space
NEW YORK, NY, Nov. 02, 2023 (GLOBE NEWSWIRE) — via NewMediaWire –Image Protect Inc. (OTC:IMTL) (Imageprotectcorporation.com) (“Image Protect” ...
November 2, 2023, 11:30 am
Kura oncology and mirati therapeutics enter into clinical collaboration and supply agreement to evaluate ko-2806 and adagrasib in krasᴳ¹²ᶜ-mutated nsclc
– Ongoing Phase 1 dose-escalation trial of KO-2806 (FIT-001) expected to begin dosing patients in combination with adagrasib by mid-2024 – SAN DIE...
November 2, 2023, 11:30 am
Intra-cellular therapies reports third quarter 2023 financial results and raises 2023 caplyta sales guidance
Q3 2023 total revenues increased to $126.2 million, compared to $71.9 million in the same period in 2022 CAPLYTA Q3 2023 net product sales were $125.8...
November 2, 2023, 11:30 am
Ocugen to host conference call on thursday, november 9 at 8:30 a.m. et to discuss business updates and third quarter 2023 financial results
MALVERN, Pa., Nov. 02, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, ...
November 2, 2023, 11:30 am